<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        17-631-24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BISCOR 5MG F.C. TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        BISOPROLOL FUMARATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Pharma International Co." />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Pharma International Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Med City Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Bisoprolol belongs to a group of medicines called beta-blockers. These medicines</p><p>work by affecting the body&#39;s response to some nerve impulses, especially in the heart.</p><p>As a result, Bisoprolol slows down the heart rate and makes the heart more efficient at pumping blood around the body.</p><p>Heart failure occurs when the heart muscle is weak and unable to pump enough blood to supply the body&#39;s needs.</p><p>&nbsp;</p><p>Indications: Treatment of Hypertension &bull; Treatment of stable chronic angina &bull;Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><u>Do not take </u><u>Biscor<sup>&reg;</sup></u><u> Tablets </u><u>if one of the following conditions applies to you:</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to bisoprolol fumarate or to any of the other ingredients of this medicine (listed in section 6: further information).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe asthma or severe chronic lung disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe blood circulation problems in your limbs (such as Raynaud&rsquo;s syndrome), which may cause your fingers and toes to tingle or turn pale or blue</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Untreated phaeochromocytoma, which is a rare tumor of the adrenal gland</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metabolic acidosis, which is a condition when there, is too much acid in the blood.</p><p><u>Do not take </u><strong><u>Biscor<sup>&reg;</sup></u></strong><u> Tablets</u><u> if you have one of the following heart problems:</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Heart failure that suddenly becomes worse and/or that may require hospital treatment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slow or irregular heart rate.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very low blood pressure.</p><p>Warnings and precautions</p><p>Talk to your doctor, pharmacist or nurse before taking Bisoprolol especially if you have any of the following conditions, he or she may want to take special care (for example give additional treatment or perform more frequent checks):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diabetes (Bisoprolol can hide the symptoms of low blood sugar)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Strict fasting.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain heart diseases such as disturbances in heart rhythm, or severe chest pain at rest (Prinzmetal&rsquo;s angina).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney or liver problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood circulation problems in your limbs.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asthma or chronic lung disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; History of a scaly rash (psoriasis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tumor of the adrenal gland (phaeochromocytoma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thyroid disorder (Bisoprolol can hide symptoms of an overactive thyroid)</p><p>In addition, tell your doctor if you are going to have:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Desensitization therapy (for example for the prevention of hay fever), because Bisoprolol may make it more likely that you experience an allergic reaction, or such reaction may be more severe.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anesthesia (for example for surgery), because Bisoprolol may influence how your body reacts to this situation.</p><p>Taking other medicines</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Do not take the following medicines with Bisoprolol without special advice from your doctor:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat irregular or abnormal heartbeat (medicines such as quinidine, disopyramide, lidocaine, phenytoin; flecainide, propafenone).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat high blood pressure, angina pectoris or irregular heartbeat (calcium antagonists such as verapamil and diltiazem).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat high blood pressure such as clonidine, methyldopa, moxonodine, rilmenidine. However,&nbsp;<strong>do not stop taking these medicines</strong>&nbsp;without checking with your doctor first.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Check with your doctor before taking the following medicines with </u><u>Bisoprolol</u><u> your doctor may need to check your condition more frequently:</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat high blood pressure or angina pectoris (such as felodipine and amlodipine).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat irregular or abnormal heartbeat (medicines such as amiodarone).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Timolol eye drops (and related medicines) for glaucoma treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Certain medicines used to treat for example Alzheimer&rsquo;s disease or glaucoma (such as tacrine or carbachol) or medicines that are used to treat acute heart problems (such as isoprenaline and dobutamine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anti-diabetic medicines including insulin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Anesthetic agents (for example during surgery).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin, used to treat heart failure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-steroidal anti-inflammatory medicines (NSAIDs) used to treat arthritis, pain or inflammation (for example ibuprofen or diclofenac)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Any medicine, that can lower blood pressure such as antihypertensive, certain medicines for depression (such as imipramine or amitriptyline), certain medicines used to treat epilepsy or during anesthesia (such as phenobarbital), or certain medicines to treat mental illness (such as levomepromazine)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mefloquine, used for prevention or treatment of malaria.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depression treatment medicines called monoamine oxidase inhibitors (except MAO-B inhibitors) such as moclobemide.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Some medicines for migraine (ergotamine derivatives).</p><p>Pregnancy and breast-feeding</p><p>There is a risk that use of Bisoprolol during pregnancy may harm the baby. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>It is not known whether Bisoprolol passes into human breast milk. Therefore, breastfeeding is not recommended during therapy with Bisoprolol.</p><p>Driving and using machines</p><p>Your ability to drive or use machinery may be affected depending on how well you tolerate the medicine. Please be especially cautious at the start of treatment, when the dose is increased or the medication is changed, as well as in combination with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>Treatment with Bisoprolol requires regular monitoring by your doctor. This is</p><p>particularly necessary at the start of treatment and during dose increase.</p><p>Take the tablet with some water in the morning, with or without food. Do not crush or chew the tablet.</p><p>Treatment with Bisoprolol is usually long-term.</p><p>Adults including the elderly</p><p>Treatment with Bisoprolol must be started at a low dose and increased gradually. Your doctor will decide how to increase the dose, and this will normally be done in the following way:</p><p>2.5mg Bisoprolol once daily for one week.</p><p>5mg Bisoprolol once daily for four weeks.</p><p>7.5mg Bisoprolol once daily for four weeks.</p><p>10mg Bisoprolol once daily for maintenance (on-going) therapy.</p><p>The maximum recommended daily dose is 10mg Bisoprolol.</p><p>Depending on how well you tolerate the medicine, your doctor may also decide to lengthen the time between dose increases. If your condition gets worse or you no</p><p>longer tolerate the drug, it may be necessary to reduce the dose again or to interrupt</p><p>treatment. In some patients a maintenance dose lower than 10mg Bisoprolol may be sufficient. Your doctor will tell you what to do.</p><p>If you have to stop treatment entirely, your doctor will usually advise you to reduce the</p><p>dose gradually, as otherwise your condition may become worse.</p><p>Children</p><p>Bisoprolol is not recommended for use in children.</p><p>If you take more Biscor&reg; than you should</p><p>If you have taken more Biscor than you should, tell your doctor immediately. Your doctor will decide what measures are necessary.</p><p>Symptoms of an overdose may include dizziness, light-headedness, fatigue,</p><p>breathlessness and/or wheezing. Also, there may be reduced heart rate, reduced blood pressure, insufficient action of the heart and a low blood glucose level (which may</p><p>involve feelings of hunger, sweating and palpitations).</p><p>If you forget to take Biscor&reg;</p><p>Do not take a double dose to make up for a forgotten dose. Take your usual dose the</p><p>next morning</p><p>If you stop taking Biscor&reg;</p><p>Never stop taking Biscor&reg; unless on your doctor&#39;s advice. Otherwise your condition</p><p>could become much worse.</p><p>If you have any further questions on the use of this medicine, ask your doctor,</p><p>pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>To prevent serious reactions, speak to a doctor immediately if a side effect is severe, occurred suddenly or gets worse rapidly.</p><p>The most serious side effects are related to the heart function:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Slowing of heart rate (affects more than 1 person in 10).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; worsening of heart failure (affects less than 1 person in 10)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow or irregular heartbeat (affects less than 1 person in 100)</p><p>If you feel dizzy or weak, or have breathing difficulties please contact your doctor as soon as possible.</p><p>Further side effects are listed below according to how frequently they may occur:</p><p>Common: (affects less than 1 person in 10)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tiredness, feeling weak, dizziness, headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling of coldness or numbness in hands or feet</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomach or intestine problems such as nausea, vomiting, diarrhea, or constipation</p><p>Uncommon: (affects less than 1 person in 100)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sleep disturbances</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; breathing problems in patients with asthma or chronic lung disease</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle weakness, muscle cramps</p><p>Rare: (affects less than 1 person in 1,000)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hearing problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic runny nose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dry eyes from reduced tear flow (can be troublesome if you use contact lenses).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the liver which can cause yellowing of the skin or whites of the eyes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy-like reactions such as itching, flush, rash</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced sexual performance (potency disorder)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nightmares, hallucinations.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fainting</p><p>Very Rare: (affects less than 1 person in 10, 000)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Irritation and redness of the eye (conjunctivitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Appearance or worsening of scaly skin rash (psoriasis); psoriasis-like rash.</p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.</p><p>Do not use this medicine after the expiry date which is stated on the blister and the carton.</p><p>The expiry date refers to the last day of that month.</p><p><strong>Biscor<sup>&reg;</sup> Tablets:</strong> Store below 30<sup>0</sup> C.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is Bisoprolol fumarate.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are<strong> </strong>calcium hydrogen phosphate anhydrous, maize starch, Povidone K, sodium starch glycolate, microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, Opadry OY-L white, FD&amp;C yellow#6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Biscor® 5 mg F/C tablets: are light orange oval, biconvex bisected, engraved with PhI on one face and VV1 on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.
Pack size:30 and 500. tablets.

Biscor® 10 mg F/C tablets: are light orange oval, biconvex bisected, engraved with PhI on one face and VV2on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.

Pack size:30 tablets.
(Not all pack size may be marketed in your country)

To report any side effect
•Saudi Arabia: 
The National Pharmacovigilance Center (NPC): 
SFDA Call Center: 19999 
E-mail: npc.drug@sfda.gov.sa 
Website: https://ade.sfda.gov.sa 
•United Arab of Emirates: 
Pharmacovigilance and Medical Device Section 
P.O. Box: 1853, Tel: 80011111 
Email: pv@mohap.gov.ae 
Drug Department, Ministry of Health & Prevention 
Dubai-UAE. 
•Other GCC States: 
Please contact the relevant competent authority.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder:</strong></p><p>Med City Pharma-KSA.</p><p>Tel: 00966920003288</p><p>Fax: 00966126358138</p><p>Mobile: 00966555786968</p><p>P.O .Box: 42512 - Jeddah 21551</p><p>E-mail: MD.admin@Axantia.com</p><p>&nbsp;</p><p><strong>Manufactured by: </strong></p><p>Pharma International Company. Amman &ndash; Jordan.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                10/2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">بيزوبرولول&nbsp;ينتمي&nbsp;إلى&nbsp;مجموعة&nbsp;من&nbsp;الأدوية&nbsp;تدعي&nbsp;حاصرات&nbsp;البيتا.&nbsp;هذه&nbsp;الأدوية&nbsp;تعمل&nbsp;عن&nbsp;طريق&nbsp;التأثير&nbsp;في</p><p dir="RTL">استجابة&nbsp;الجسم&nbsp;لبعض&nbsp;النبضات&nbsp;العصبية،&nbsp;وخاصة&nbsp;في&nbsp;القلب.&nbsp;ونتيجة&nbsp;لذلك،&nbsp;بيزوبرولول&nbsp;يبطئ&nbsp;من&nbsp;معدل</p><p dir="RTL">ضربات&nbsp;القلب&nbsp;ويجعل&nbsp;القلب&nbsp;أكثر&nbsp;كفاءة&nbsp;في&nbsp;ضخ&nbsp;الدم&nbsp;في&nbsp;جميع&nbsp;انحاء&nbsp;الجسم</p><p dir="RTL">تحدث&nbsp;النوبة&nbsp;القلبية&nbsp;عندما&nbsp;تضعف&nbsp;عضلة&nbsp;القلب&nbsp;و&nbsp;تصبح&nbsp;غير&nbsp;قادرة&nbsp;على&nbsp;ضخ&nbsp;الدم&nbsp;بما&nbsp;يكفي&nbsp;لتزويد&nbsp;احتياجات</p><p dir="RTL">الجسم.&nbsp;الاستطبابات:&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم&nbsp;وعلاج&nbsp;الذبحة&nbsp;الصدرية&nbsp;المزمنة&nbsp;المستقرة&nbsp;وعلاج&nbsp;الفشل</p><p dir="RTL">القلبي&nbsp;المزمن&nbsp;المستقر&nbsp;مع&nbsp;انخفاض&nbsp;ضغط&nbsp;الدم&nbsp;الانقباضي&nbsp;للبطين&nbsp;الأيسر&nbsp;بالإضافة&nbsp;إلى&nbsp;مثبطات&nbsp;ال</p><p>ACE&nbsp;ومدرات&nbsp;البول,&nbsp;وجليكوسيدات&nbsp;القلب&nbsp;اختياريا</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا&nbsp;تأخذ&nbsp;بيسكور&nbsp;أقراص&nbsp;إذا&nbsp;كان&nbsp;أحد&nbsp;الشروط&nbsp;التالية&nbsp;تنطبق&nbsp;عليك:</p><p dir="RTL">.&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;حساسية&nbsp;لبيزوبرولول&nbsp;فيوماريت&nbsp;أو&nbsp;إلى&nbsp;أي&nbsp;من&nbsp;المكونات&nbsp;الأخرى&nbsp;لهذا&nbsp;الدواء&nbsp;(المذكورة</p><p dir="RTL">في&nbsp;البند&nbsp;6:&nbsp;للمزيد&nbsp;من&nbsp;المعلومات)</p><p dir="RTL">.&nbsp;الربو&nbsp;الحاد&nbsp;أو&nbsp;أمراض&nbsp;الرئة&nbsp;المزمنة&nbsp;الشديدة</p><p dir="RTL">&bull;&nbsp;مشاكل&nbsp;حادة&nbsp;في&nbsp;الدورة&nbsp;الدموية&nbsp;في&nbsp;الأطراف&nbsp;(مثل&nbsp;متلازمة&nbsp;رينود)&nbsp;،&nbsp;مما&nbsp;قد&nbsp;يتسبب&nbsp;بارتعاش&nbsp;أصابعك</p><p dir="RTL">وأصابع&nbsp;القدمين&nbsp;و&nbsp;ميل&nbsp;لونها&nbsp;للشحوب&nbsp;أو&nbsp;اللون&nbsp;الأزرق</p><p dir="RTL">&bull;&nbsp;ورم&nbsp;القوائم&nbsp;غير&nbsp;المعالجة،&nbsp;وهو&nbsp;ورم&nbsp;نادر&nbsp;في&nbsp;الغدة&nbsp;الكظرية</p><p dir="RTL">و&nbsp;الحماض&nbsp;الأيضي،&nbsp;وهي&nbsp;حالة&nbsp;تكون&nbsp;فيها&nbsp;نسبة&nbsp;الحمض&nbsp;عالية&nbsp;في&nbsp;الدم</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا&nbsp;تأخذ&nbsp;بيسكور&nbsp;أقراص&nbsp;إذا&nbsp;كان&nbsp;لديك&nbsp;واحدة&nbsp;من&nbsp;مشاكل&nbsp;في&nbsp;القلب&nbsp;التالية:</p><p dir="RTL">&bull;&nbsp;نوبة&nbsp;قلبية&nbsp;و&nbsp;التي&nbsp;قد&nbsp;تسوء&nbsp;حالتها&nbsp;فجأة&nbsp;و&nbsp;/&nbsp;أو&nbsp;التي&nbsp;قد&nbsp;تتطلب&nbsp;العلاج&nbsp;في&nbsp;المستشفى</p><p dir="RTL">&bull;&nbsp;معدل&nbsp;ضربات&nbsp;القلب&nbsp;بطيئة&nbsp;أو&nbsp;غير&nbsp;منتظمة</p><p dir="RTL">&bull;&nbsp;انخفاض&nbsp;شديد&nbsp;في&nbsp;ضغط&nbsp;الدم</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">التحذيرات&nbsp;والاحتياطات</p><p dir="RTL">تحدث&nbsp;إلى&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;أو&nbsp;الممرضة&nbsp;قبل&nbsp;استخدام&nbsp;بيزوبرولول&nbsp;خاصة&nbsp;إذا&nbsp;كنت&nbsp;تعاني&nbsp;من&nbsp;أي&nbsp;من</p><p dir="RTL">الحالات&nbsp;التالية،&nbsp;قد&nbsp;يحتاج&nbsp;او&nbsp;تحتاج&nbsp;إلى&nbsp;اتخاذ&nbsp;احتياطات&nbsp;خاصة&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;إضافة&nbsp;علاج&nbsp;أو&nbsp;القيام</p><p dir="RTL">بفحوصات&nbsp;متكررة&nbsp;إضافية):</p><p dir="RTL">&bull;&nbsp;السكري&nbsp;(قد&nbsp;يخفي&nbsp;البيزوبرولول&nbsp;أعراض&nbsp;انخفاض&nbsp;السكر&nbsp;في&nbsp;الدم)</p><p dir="RTL">&bull;&nbsp;صيام&nbsp;قاسي</p><p dir="RTL">&bull;&nbsp;أمراض&nbsp;قلب&nbsp;معينة&nbsp;مثل&nbsp;اضطرابات&nbsp;في&nbsp;إيقاع&nbsp;القلب،&nbsp;أو&nbsp;الم&nbsp;شديد&nbsp;في&nbsp;الصدر&nbsp;عند&nbsp;الراحة&nbsp;(الذبحة&nbsp;الصدرية</p><p dir="RTL">برنز&nbsp;مینال)</p><p dir="RTL">&bull;&nbsp;&nbsp;مشاكل&nbsp;في&nbsp;الكلى&nbsp;أو&nbsp;الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;مشاكل&nbsp;في&nbsp;الدورة&nbsp;الدموية&nbsp;عند&nbsp;الأطراف</p><p dir="RTL">&bull;&nbsp;الربو&nbsp;أو&nbsp;أمراض&nbsp;الرئة&nbsp;المزمنة</p><p dir="RTL">&bull;&nbsp;تاريخ&nbsp;من&nbsp;الطفح&nbsp;ذو&nbsp;القشور&nbsp;الصيفية</p><p dir="RTL">&bull;&nbsp;ورم&nbsp;الغدة&nbsp;الكظرية&nbsp;(ورم&nbsp;القواتم)</p><p dir="RTL">&bull;&nbsp;&nbsp;اضطراب&nbsp;الغدة&nbsp;الدرقية&nbsp;(قد&nbsp;يخفي&nbsp;البيزوبرولول&nbsp;أعراض&nbsp;فرط&nbsp;نشاط&nbsp;الغدة&nbsp;الدرقية</p><p dir="RTL">وبالإضافة&nbsp;إلى&nbsp;ذلك،&nbsp;أخبر&nbsp;طبيبك&nbsp;إذا&nbsp;كنت&nbsp;على&nbsp;وشك:</p><p dir="RTL">&bull;&nbsp;معالجة&nbsp;الحساسية&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;للوقاية&nbsp;من&nbsp;حمى&nbsp;القش)&nbsp;،&nbsp;وذلك&nbsp;لأن&nbsp;بيزوبرولول&nbsp;قد&nbsp;يزيد&nbsp;احتمالية&nbsp;أن</p><p dir="RTL">تعاني&nbsp;من&nbsp;الحساسية،&nbsp;أو&nbsp;قد&nbsp;تكون&nbsp;ردة&nbsp;الفعل&nbsp;هذه&nbsp;أكثر&nbsp;شدة</p><p dir="RTL">.&nbsp;التخدير&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;لإجراء&nbsp;عملية&nbsp;جراحية&nbsp;،&nbsp;وذلك&nbsp;لأن&nbsp;بيزوبرولول&nbsp;قد&nbsp;يؤثر&nbsp;على&nbsp;جسمك&nbsp;كيف</p><p dir="RTL">يتفاعل&nbsp;مع&nbsp;هذا&nbsp;الوضع</p><p dir="RTL">تناول&nbsp;أدوية&nbsp;أخرى</p><p dir="RTL">أخبر&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;إذا&nbsp;كنت&nbsp;تستخدم،&nbsp;وقد&nbsp;استخدمت&nbsp;مؤخرا&nbsp;أو&nbsp;قد&nbsp;تستخدم&nbsp;أي&nbsp;أدوية&nbsp;أخرى.</p><p dir="RTL">لا&nbsp;تأخذ&nbsp;الأدوية&nbsp;التالية&nbsp;مع&nbsp;بيزوبرولول&nbsp;دون&nbsp;مشورة&nbsp;خاصة&nbsp;من&nbsp;الطبيب</p><p dir="RTL">&bull;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;ضربات&nbsp;القلب&nbsp;غير&nbsp;المنتظمة&nbsp;أو&nbsp;غير&nbsp;الطبيعية&nbsp;(الأدوية&nbsp;مثل&nbsp;كينيدين،</p><p dir="RTL">ديسوبيراميد،&nbsp;ليدوكائين،&nbsp;فينيتوين؛&nbsp;فليكيناید،&nbsp;بروبافينون)</p><p dir="RTL">&bull;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم،&nbsp;والذبحة&nbsp;الصدرية&nbsp;أو&nbsp;عدم&nbsp;انتظام&nbsp;ضربات&nbsp;القلب</p><p dir="RTL">مضادات&nbsp;الكالسيوم&nbsp;مثل&nbsp;فيرابامیل&nbsp;و&nbsp;دیلتیازیم)</p><p dir="RTL">&bull;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم&nbsp;مثل&nbsp;الكلونيدين،&nbsp;ميثيل&nbsp;دوبا،&nbsp;مونوکسیدین،&nbsp;ريلميندين.</p><p dir="RTL">ومع&nbsp;ذلك،&nbsp;لا&nbsp;تتوقف&nbsp;عن&nbsp;تناول&nbsp;هذه&nbsp;الأدوية&nbsp;دون&nbsp;الرجوع&nbsp;لطبيبك&nbsp;أولا.</p><p dir="RTL">استشر&nbsp;طبيبك&nbsp;قبل&nbsp;تناول&nbsp;الأدوية&nbsp;التالية&nbsp;مع&nbsp;بيزوبرولول،&nbsp;و&nbsp;ذلك&nbsp;لأن&nbsp;طبيبك&nbsp;قد&nbsp;يحتاج&nbsp;لمراجعة&nbsp;حالتك&nbsp;بشكل</p><p dir="RTL">أكثر&nbsp;تكرارا:</p><p dir="RTL">&bull;&nbsp;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;ارتفاع&nbsp;ضغط&nbsp;الدم&nbsp;أو&nbsp;الذبحة&nbsp;الصدرية&nbsp;(مثل&nbsp;فيلوديبين&nbsp;والأملوديبين)</p><p dir="RTL">&bull;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;ضربات&nbsp;القلب&nbsp;غير&nbsp;المنتظمة&nbsp;أو&nbsp;غير&nbsp;الطبيعية&nbsp;(الأدوية&nbsp;مثل&nbsp;الأميودارون)</p><p dir="RTL">&bull;&nbsp;قطرات&nbsp;العين&nbsp;تيمولول&nbsp;(والأدوية&nbsp;ذات&nbsp;الصلة)&nbsp;لعلاج&nbsp;الجلوكوما</p><p dir="RTL">&bull;&nbsp;بعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;على&nbsp;سبيل&nbsp;المثال&nbsp;مرض&nbsp;الزهايمر&nbsp;أو&nbsp;الزرق&nbsp;(مثل&nbsp;تاكرين&nbsp;أو&nbsp;كرياكول)</p><p dir="RTL">أو&nbsp;الأدوية&nbsp;التي&nbsp;تستخدم&nbsp;لعلاج&nbsp;مشاكل&nbsp;القلب&nbsp;الحادة&nbsp;(مثل&nbsp;ایزو&nbsp;برينالين&nbsp;و&nbsp;الدوبوتامين)</p><p dir="RTL">&bull;&nbsp;الأدوية&nbsp;المضادة&nbsp;للسكري&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;الأنسولين</p><p dir="RTL">&bull;&nbsp;التخدير&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;أثناء&nbsp;الجراحة)</p><p dir="RTL">&bull;&nbsp;الديجوكسين،&nbsp;ويستخدم&nbsp;لعلاج&nbsp;النوبات&nbsp;القلبية</p><p dir="RTL">&bull;&nbsp;الأدوية&nbsp;المضادة&nbsp;للالتهابات&nbsp;غير&nbsp;الستيرويدية&nbsp;(المسكنات&nbsp;المستخدمة&nbsp;لعلاج&nbsp;التهاب&nbsp;المفاصل،&nbsp;الألام&nbsp;أو</p><p dir="RTL">التهابات&nbsp;(على&nbsp;سبيل&nbsp;المثال&nbsp;الإيبوبروفين&nbsp;أو&nbsp;ديكلوفيناك)</p><p dir="RTL">و&nbsp;أي&nbsp;دواء،&nbsp;يمكن&nbsp;أن&nbsp;يخفض&nbsp;ضغط&nbsp;الدم&nbsp;مثل&nbsp;مضادات&nbsp;ارتفاع&nbsp;الضغط&nbsp;بعض&nbsp;الأدوية&nbsp;لعلاج&nbsp;الاكتئاب&nbsp;(مثل</p><p dir="RTL">إيميبرامين&nbsp;أو&nbsp;أميتريبتيلين)،&nbsp;وبعض&nbsp;الأدوية&nbsp;المستخدمة&nbsp;لعلاج&nbsp;الصرع&nbsp;أو&nbsp;أثناء&nbsp;التخدير&nbsp;(مثل&nbsp;الفينوباربیتال)،</p><p dir="RTL">أو&nbsp;بعض&nbsp;الأدوية&nbsp;لعلاج&nbsp;الأمراض&nbsp;النفسية&nbsp;(مثل&nbsp;ليقومیبرومازین)</p><p dir="RTL">و&nbsp;الميفلوكين،&nbsp;وتستخدم&nbsp;لمنع&nbsp;أو&nbsp;علاج&nbsp;الملاريا.</p><p dir="RTL">.&nbsp;أدوية&nbsp;لعلاج&nbsp;الاكتئاب&nbsp;تدعى&nbsp;مثبطات&nbsp;مونو&nbsp;أمين&nbsp;أوكسيديز&nbsp;(باستثناء&nbsp;مثبطات&nbsp;MAO-B)&nbsp;مثل&nbsp;موکلوبمید.</p><p dir="RTL">.&nbsp;بعض&nbsp;أدوية&nbsp;الصداع&nbsp;النصفي&nbsp;(مشتقات&nbsp;الإرغوتامین)</p><p dir="RTL">&nbsp;</p><p dir="RTL">الحمل&nbsp;والرضاعة&nbsp;الطبيعية</p><p dir="RTL">هناك&nbsp;خطورة&nbsp;تتمثل&nbsp;في&nbsp;أن&nbsp;استخدام&nbsp;بيزوبرولول&nbsp;خلال&nbsp;فترة&nbsp;الحمل&nbsp;قد&nbsp;يؤذي&nbsp;الجنين.&nbsp;إذا&nbsp;كنت&nbsp;حاملا&nbsp;أو</p><p dir="RTL">ترضعين&nbsp;طبيعية،&nbsp;أو&nbsp;تعتقدين&nbsp;أنك&nbsp;حامل&nbsp;أو&nbsp;تخططين&nbsp;لإنجاب&nbsp;طفل،&nbsp;إسأل&nbsp;طبيبك&nbsp;للحصول&nbsp;على&nbsp;المشورة&nbsp;قبل</p><p dir="RTL">استخدام&nbsp;هذا&nbsp;الدواء</p><p dir="RTL">من&nbsp;غير&nbsp;المعروف&nbsp;ما&nbsp;إذا&nbsp;كان&nbsp;البيزوبرولول&nbsp;يخرج&nbsp;مع&nbsp;حليب&nbsp;الأم&nbsp;المرضعة&nbsp;أم&nbsp;لا،&nbsp;ولذلك&nbsp;فمن&nbsp;غير&nbsp;المستحسن</p><p dir="RTL">الرضاعة&nbsp;الطبيعية&nbsp;أثناء&nbsp;فترة&nbsp;العلاج&nbsp;بالبيزوبرولول</p><p dir="RTL">&nbsp;</p><p dir="RTL">القيادة&nbsp;واستخدام&nbsp;الآلات</p><p dir="RTL">قدرتك&nbsp;على&nbsp;القيادة&nbsp;أو&nbsp;استخدام&nbsp;الآلات&nbsp;قد&nbsp;تتأثر&nbsp;تبعا&nbsp;لكيفية&nbsp;تجاوبك&nbsp;مع&nbsp;الدواء.&nbsp;يرجى&nbsp;الحذر&nbsp;خصوصأ&nbsp;في&nbsp;بداية</p><p dir="RTL">العلاج،&nbsp;عند&nbsp;زيادة&nbsp;الجرعة&nbsp;أو&nbsp;تغيير&nbsp;الدواء،&nbsp;وكذلك&nbsp;عند&nbsp;استخدامه&nbsp;بالتزامن&nbsp;مع&nbsp;تناول&nbsp;الكحول.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم&nbsp;هذا&nbsp;الدواء&nbsp;تماما&nbsp;كما&nbsp;أخبرك&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي.&nbsp;قم&nbsp;بمراجعة&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;إذا&nbsp;كنت&nbsp;غيرمتأكد</p><p dir="RTL">العلاج&nbsp;مع&nbsp;بيزوبرولول&nbsp;يتطلب&nbsp;مراقبة&nbsp;منتظمة&nbsp;من&nbsp;قبل&nbsp;الطبيب.&nbsp;هذا&nbsp;أمر&nbsp;ضروري&nbsp;بصفة&nbsp;خاصة&nbsp;في&nbsp;بداية</p><p dir="RTL">العلاج،&nbsp;وخلال&nbsp;زيادة&nbsp;الجرعة</p><p dir="RTL">يؤخذ&nbsp;قرص&nbsp;الدواء&nbsp;مع&nbsp;بعض&nbsp;الماء&nbsp;في&nbsp;الصباح،&nbsp;مع&nbsp;الطعام&nbsp;أو&nbsp;بدونه.&nbsp;لا&nbsp;تسحق&nbsp;أو&nbsp;تمضغ&nbsp;القرص.</p><p dir="RTL">العلاج&nbsp;بالبیزوپرولول&nbsp;هو&nbsp;علاج&nbsp;طويل&nbsp;الأمد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">البالغين&nbsp;بما&nbsp;في&nbsp;ذلك&nbsp;كبار&nbsp;السن</p><p dir="RTL">يجب&nbsp;بدء&nbsp;العلاج&nbsp;بالبيزوبرولول&nbsp;بجرعة&nbsp;منخفضة&nbsp;و&nbsp;تزداد&nbsp;تدريجيا.&nbsp;طبيبك&nbsp;سوف&nbsp;يقرر&nbsp;كيفية&nbsp;زيادة&nbsp;الجرعة</p><p dir="RTL">وهذا&nbsp;عادة&nbsp;سيتم&nbsp;على&nbsp;النحو&nbsp;التالي</p><p dir="RTL">2.5&nbsp;ملغم&nbsp;بيزوبرولول&nbsp;مرة&nbsp;يوميا&nbsp;لمدة&nbsp;أسبوع&nbsp;واحد</p><p dir="RTL">5&nbsp;ملغم&nbsp;بیزوپرولول&nbsp;مرة&nbsp;يوميا&nbsp;لمدة&nbsp;اربع&nbsp;اسابيع.</p><p dir="RTL">7.5&nbsp;ملغم&nbsp;بيزوبر&nbsp;أول&nbsp;مرة&nbsp;يوميا&nbsp;لمدة&nbsp;أربع&nbsp;أسابيع</p><p dir="RTL">10&nbsp;ملغم&nbsp;بيزوبرولول&nbsp;مرة&nbsp;يوميا&nbsp;للمعالجة&nbsp;على&nbsp;الأمد&nbsp;الطويل&nbsp;(المعالجة&nbsp;الجارية).</p><p dir="RTL">الحد&nbsp;الأقصى&nbsp;للجرعة&nbsp;اليومية&nbsp;الموصى&nbsp;بها&nbsp;من&nbsp;البيزوبرولول&nbsp;هي&nbsp;10&nbsp;ملغم</p><p dir="RTL">&nbsp;</p><p dir="RTL">اعتمادا&nbsp;على&nbsp;مدى&nbsp;تجاوبك&nbsp;مع&nbsp;الدواء،&nbsp;فإن&nbsp;طبيبك&nbsp;سيقرر&nbsp;إطالة&nbsp;الوقت&nbsp;بين&nbsp;فترات&nbsp;زيادة&nbsp;الجرعة.&nbsp;إذا&nbsp;كانت</p><p dir="RTL">حالتك&nbsp;تسوء&nbsp;أو&nbsp;أنك&nbsp;لم&nbsp;تعد&nbsp;تتجاوب&nbsp;بشكل&nbsp;جيد&nbsp;مع&nbsp;الدواء،&nbsp;فقد&nbsp;يكون&nbsp;من&nbsp;الضروري&nbsp;خفض&nbsp;الجرعة&nbsp;مرة&nbsp;أخرى</p><p dir="RTL">أو&nbsp;التوقف&nbsp;عن&nbsp;العلاج&nbsp;عند&nbsp;بعض&nbsp;المرضى&nbsp;قد&nbsp;تكون&nbsp;الجرعة&nbsp;الثابتة&nbsp;المناسبة&nbsp;من&nbsp;البيزوبرولول&nbsp;أقل&nbsp;من&nbsp;10</p><p dir="RTL">ملغم. سيخبرك&nbsp;طبيبك&nbsp;بما&nbsp;عليك&nbsp;فعله</p><p dir="RTL">إذا&nbsp;كان&nbsp;عليك&nbsp;التوقف&nbsp;عن&nbsp;العلاج&nbsp;تماما،&nbsp;عادة&nbsp;طبيبك&nbsp;سوف&nbsp;ينصحك&nbsp;بتقليل&nbsp;الجرعة&nbsp;تدريجيا،&nbsp;وإلا&nbsp;قد&nbsp;تصبح</p><p dir="RTL">حالتك&nbsp;اسوأ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأطفال</p><p dir="RTL">لا&nbsp;ينصح&nbsp;باستخدام&nbsp;بيزوبرولول&nbsp;للأطفال</p><p dir="RTL">إذا&nbsp;أخذت&nbsp;بيسكور&nbsp;أقراص&nbsp;أكثر&nbsp;مما&nbsp;يجب</p><p dir="RTL">إذا&nbsp;أخذت&nbsp;بيسكور&nbsp;أكثر&nbsp;مما&nbsp;يجب،&nbsp;أخبر&nbsp;طبيبك&nbsp;فورا.&nbsp;طبيبك&nbsp;سوف&nbsp;يقرر&nbsp;ما&nbsp;هي&nbsp;التدابير&nbsp;اللازمة&nbsp;لذلك</p><p dir="RTL">أعراض&nbsp;الجرعة&nbsp;الزائدة&nbsp;قد&nbsp;تتضمن&nbsp;الدوخة،&nbsp;الدوار،&nbsp;والتعب،&nbsp;وضيق&nbsp;في&nbsp;التنفس&nbsp;و&nbsp;/&nbsp;أو&nbsp;الصفير.&nbsp;كذلك،&nbsp;قد</p><p dir="RTL">ينخفض&nbsp;معدل&nbsp;ضربات&nbsp;القلب،&nbsp;انخفاض&nbsp;ضغط&nbsp;الدم،&nbsp;عمل&nbsp;القلب&nbsp;بكفاءة&nbsp;أقل،&nbsp;وانخفاض&nbsp;مستوى&nbsp;السكر&nbsp;في&nbsp;الدم</p><p dir="RTL">والتي&nbsp;قد&nbsp;تتضمن&nbsp;الشعور&nbsp;بالجوع،&nbsp;والتعرق&nbsp;والخفقان)</p><p dir="RTL">إذا&nbsp;نسيت&nbsp;أن&nbsp;تأخذ&nbsp;بيسكور&nbsp;أقراص</p><p dir="RTL">لا&nbsp;تأخذ&nbsp;عة&nbsp;مضاعفة&nbsp;لتعويض&nbsp;الجرعة&nbsp;المنسية.&nbsp;خذ&nbsp;جرعتك&nbsp;المعتادة&nbsp;في&nbsp;صباح&nbsp;اليوم&nbsp;التالي.</p><p dir="RTL">إذا&nbsp;توقفت&nbsp;عن&nbsp;تناول&nbsp;بيسكور&nbsp;أقراص</p><p dir="RTL">لا&nbsp;تتوقف&nbsp;عن&nbsp;تناول&nbsp;بيسكور&nbsp;إلا&nbsp;بناء&nbsp;على&nbsp;نصيحة&nbsp;الطبيب.&nbsp;وإلا&nbsp;حالتك&nbsp;قد&nbsp;تصبح&nbsp;أسوأ&nbsp;بكثير.</p><p>إذا&nbsp;كان&nbsp;لديك&nbsp;أي&nbsp;أسئلة&nbsp;أخرى&nbsp;حول&nbsp;استخدام&nbsp;هذا&nbsp;الدواء،&nbsp;اسال&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;أو&nbsp;الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل&nbsp;باقي&nbsp;الأدوية،&nbsp;قد&nbsp;يتسبب&nbsp;هذا&nbsp;الدواء&nbsp;بآثار&nbsp;جانبية،&nbsp;وإن&nbsp;لم&nbsp;يعاني&nbsp;الجميع&nbsp;منها.</p><p dir="RTL">لمنع&nbsp;ردود&nbsp;الفعل&nbsp;الخطيرة،&nbsp;راجع&nbsp;الطبيب&nbsp;فورا&nbsp;في&nbsp;حال&nbsp;اشتدت&nbsp;أي&nbsp;من&nbsp;الآثار&nbsp;الجانبية،&nbsp;أو&nbsp;ظهرت&nbsp;فجاة&nbsp;أو&nbsp;ساء</p><p dir="RTL">وضعها بسرعة</p><p dir="RTL">الأثار&nbsp;الجانبية&nbsp;الأكثر&nbsp;خطورة&nbsp;ترتبط&nbsp;بوظيفة&nbsp;القلب:</p><p dir="RTL">&bull;&nbsp;تباطؤ&nbsp;معدل&nbsp;ضربات&nbsp;القلب&nbsp;(يؤثر&nbsp;على&nbsp;أكثر&nbsp;من&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;10&nbsp;مستخدمین)</p><p dir="RTL">&bull;&nbsp;تدهور&nbsp;وضع&nbsp;السكتة&nbsp;القلبية&nbsp;القلب&nbsp;(يؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;10&nbsp;مستخدمین)</p><p dir="RTL">&bull;&nbsp;&nbsp;بطء&nbsp;أو&nbsp;عدم&nbsp;انتظام&nbsp;نبض&nbsp;القلب&nbsp;(يؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;المستخدم&nbsp;من&nbsp;أصل&nbsp;100&nbsp;مستخدم)</p><p dir="RTL">إذا&nbsp;كنت&nbsp;تشعر&nbsp;بالدوار&nbsp;أو&nbsp;الضعف،&nbsp;أو&nbsp;صعوبات&nbsp;في&nbsp;التفس،&nbsp;يرجى&nbsp;مراجعة&nbsp;طبيبك&nbsp;في&nbsp;أقرب&nbsp;وقت&nbsp;ممكن</p><p dir="RTL">&nbsp;</p><p dir="RTL">آثار&nbsp;جانبية&nbsp;إضافية&nbsp;مدرجة&nbsp;أدناه&nbsp;وفقا&nbsp;لتكرار&nbsp;حدوثها&nbsp;:</p><p dir="RTL">&nbsp;</p><p dir="RTL">شائعة&nbsp;(يؤثر&nbsp;على&nbsp;اقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;10&nbsp;مستخدمین)</p><p dir="RTL">&bull;&nbsp;التعب،&nbsp;والشعور&nbsp;بالضعف،&nbsp;والدوخة،&nbsp;والصداع</p><p dir="RTL">.&nbsp;الشعور&nbsp;ببرودة&nbsp;أو&nbsp;خدر&nbsp;في&nbsp;اليدين&nbsp;أو&nbsp;القدمين</p><p dir="RTL">.&nbsp;انخفاض&nbsp;ضغط&nbsp;الدم</p><p dir="RTL">&bull;&nbsp;مشاكل&nbsp;في&nbsp;المعدة&nbsp;أو&nbsp;الأمعاء&nbsp;مثل&nbsp;الغثيان،&nbsp;القيء،&nbsp;الإسهال،&nbsp;أو&nbsp;الإمساك</p><p dir="RTL">&nbsp;</p><p dir="RTL">غیر&nbsp;شائع&nbsp;(&nbsp;يؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;100&nbsp;مستخدم)</p><p dir="RTL">&bull;&nbsp;اضطرابات&nbsp;النوم</p><p dir="RTL">&bull;&nbsp;&nbsp;الاكتناب</p><p dir="RTL">&bull;&nbsp;مشاكل&nbsp;في&nbsp;التنفس&nbsp;عند&nbsp;المرضى&nbsp;الذين&nbsp;يعانون&nbsp;من&nbsp;الربو&nbsp;أو&nbsp;أمراض&nbsp;الرنة&nbsp;المزمنة</p><p dir="RTL">&bull;&nbsp;ضعف&nbsp;العضلات،&nbsp;وتشنجات&nbsp;العضلات</p><p dir="RTL">&nbsp;</p><p dir="RTL">نادرة&nbsp;(&nbsp;يؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;1000&nbsp;مستخدم)</p><p dir="RTL">.&nbsp;مشاكل&nbsp;في&nbsp;السمع</p><p dir="RTL">&bull;&nbsp;سيلان&nbsp;الأنف&nbsp;التحسسي</p><p dir="RTL">.&nbsp;جفاف&nbsp;العين&nbsp;من&nbsp;انخفاض&nbsp;تدفق&nbsp;الدموع&nbsp;(قد&nbsp;تكون&nbsp;مزعجة&nbsp;إذا&nbsp;كنت&nbsp;تستخدم&nbsp;العدسات&nbsp;اللاصقة)</p><p dir="RTL">.&nbsp;التهاب&nbsp;الكبد&nbsp;الذي&nbsp;يمكن&nbsp;أن&nbsp;يسبب&nbsp;اصفرار&nbsp;الجلد&nbsp;أو&nbsp;لبياض&nbsp;العينين</p><p dir="RTL">&bull;&nbsp;تفاعلات&nbsp;مشابهة&nbsp;للحساسية&nbsp;مثل&nbsp;الحكة،&nbsp;والاحمرار&nbsp;والطفح&nbsp;الجلدي</p><p dir="RTL">&bull;&nbsp;انخفاض&nbsp;الأداء&nbsp;الجنسي&nbsp;(اضطراب&nbsp;القدرة&nbsp;الجنسية)</p><p dir="RTL">&bull;&nbsp;الكوابيس&nbsp;والهلوسة</p><p dir="RTL">&bull;&nbsp;&nbsp;الإغماء</p><p dir="RTL">&nbsp;</p><p dir="RTL">نادرة&nbsp;جدا&nbsp;(يؤثر&nbsp;على&nbsp;أقل&nbsp;من&nbsp;1&nbsp;مستخدم&nbsp;من&nbsp;أصل&nbsp;10,000&nbsp;مستخدم)</p><p dir="RTL">&bull;&nbsp;تهيج&nbsp;وأحمرار&nbsp;في&nbsp;العين&nbsp;(التهاب&nbsp;الملتحمة)</p><p dir="RTL">&bull;&nbsp;فقدان&nbsp;الشعر</p><p dir="RTL">&bull;&nbsp;&nbsp;ظهور&nbsp;أو&nbsp;تدهور&nbsp;الطفح&nbsp;الجلدي&nbsp;ذو&nbsp;القشور&nbsp;(الصدفية)؛&nbsp;طفح&nbsp;جلدي&nbsp;شبيه&nbsp;بالصدفية</p><p dir="RTL">اذا&nbsp;عانيت&nbsp;من&nbsp;أي&nbsp;آثار&nbsp;جانبية،&nbsp;راجع&nbsp;طبيبك&nbsp;أو&nbsp;الصيدلي&nbsp;أو&nbsp;الممرضة.&nbsp;وهذا&nbsp;يشمل&nbsp;أي&nbsp;آثار&nbsp;جانبية&nbsp;غير&nbsp;المذكورة&nbsp;في&nbsp;هذه&nbsp;النشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ&nbsp;بعيدا&nbsp;عن&nbsp;متناول&nbsp;الأطفال&nbsp;و&nbsp;نظرهم</p><p dir="RTL">لا&nbsp;تستخدم&nbsp;الأقراص&nbsp;بعد&nbsp;تاريخ&nbsp;انتهاء&nbsp;الصلاحية&nbsp;(EXP&nbsp;المذكور&nbsp;على&nbsp;الشريط&nbsp;و&nbsp;العلبة&nbsp;الخارجية.</p><p dir="RTL">تاريخ&nbsp;الانتهاء&nbsp;يشير&nbsp;إلى&nbsp;اليوم&nbsp;الأخير&nbsp;من&nbsp;تلك&nbsp;الشهر.</p><p dir="RTL">بيسكور أقراص:&nbsp;يحفظ&nbsp;بدرجة&nbsp;حرارة&nbsp;دون&nbsp;30 &deg;م</p><p dir="RTL">يجب&nbsp;أن&nbsp;لا&nbsp;يتم&nbsp;التخلص&nbsp;من&nbsp;الأدوية&nbsp;عن&nbsp;طريق&nbsp;مياه&nbsp;الصرف&nbsp;الصحي&nbsp;أو&nbsp;النفايات&nbsp;المنزلية.&nbsp;</p><p dir="RTL">اسال&nbsp;الصيدلي&nbsp;عن كيفية&nbsp;التخلص&nbsp;من&nbsp;الأدوية&nbsp;التي&nbsp;لم&nbsp;تعد&nbsp;مطلوبة.&nbsp;وسوف&nbsp;تساعد&nbsp;هذه&nbsp;التدابير&nbsp;في&nbsp;حماية&nbsp;البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة&nbsp;الفعالة&nbsp;بيزوبرولول&nbsp;فيوماريت</p><p dir="RTL">المكونات&nbsp;الأخرى&nbsp;هي&nbsp;فوسفات&nbsp;الكالسيوم&nbsp;ثنائي&nbsp;القاعدة،&nbsp;نشا&nbsp;الذرة،&nbsp;بوفيدون&nbsp;ك،&nbsp;جليكوليت&nbsp;نشا&nbsp;الصوديوم،</p><p dir="RTL">میکروکریستالين&nbsp;سيليلوز،&nbsp;مغنيسيوم&nbsp;ستيريت&nbsp;،&nbsp;ثنائي&nbsp;أكسيد&nbsp;السيلكون&nbsp;الغروي،&nbsp;أوبادري&nbsp;أبيض،&nbsp;الأون&nbsp;أصفر</p><p dir="RTL">FD&amp;C #6</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الشكل&nbsp;الدواني&nbsp;ل&nbsp;بيسكور&nbsp;أقراص&nbsp;وحجم&nbsp;العبوة:</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;أقراص&nbsp;بيسكورة&nbsp;5&nbsp;ملغم&nbsp;المغلفة&nbsp;غشائية&nbsp;برتقالية&nbsp;فاتحة&nbsp;اللون&nbsp;،&nbsp;بيضاوية،&nbsp;محدبة&nbsp;الوجهين&nbsp;و&nbsp;عليها&nbsp;خط</p><p dir="RTL">يسمح&nbsp;بكسرها&nbsp;لنصفين،&nbsp;محفور&nbsp;رمز&nbsp;Phl&nbsp;على&nbsp;أحد&nbsp;الأوجه&nbsp;و&nbsp;VV1&nbsp;على&nbsp;الوجه&nbsp;الثاني،&nbsp;موضوعة&nbsp;في&nbsp;شريط</p><p dir="RTL">من&nbsp;الألومنيوم&nbsp;PVC/TE/PVDC-Alu&nbsp;،&nbsp;ومعدة&nbsp;للاستخدام&nbsp;عن&nbsp;طريق&nbsp;الفم</p><p dir="RTL">حجم&nbsp;العبوة: 30&nbsp;و&nbsp;500&nbsp;قرص</p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;أقراص&nbsp;بيسكوره&nbsp;10&nbsp;ملغم&nbsp;المغلفة&nbsp;غشائية&nbsp;برتقالية&nbsp;فاتحة&nbsp;اللون،&nbsp;بيضاوية،&nbsp;محدية&nbsp;الوجهين&nbsp;و&nbsp;عليها&nbsp;خط</p><p dir="RTL">يسمح&nbsp;بكسرها&nbsp;لنصفين،&nbsp;محفور&nbsp;رمز&nbsp;Phl&nbsp;على&nbsp;أحد&nbsp;الأوجه&nbsp;و&nbsp;VV2&nbsp;على&nbsp;الوجه&nbsp;الثاني،&nbsp;موضوعة&nbsp;في&nbsp;شريط</p><p dir="RTL">من&nbsp;الألومنيوم&nbsp;PVC/TE/PVDC-Alu&nbsp;،&nbsp;و&nbsp;معدة&nbsp;للاستخدام&nbsp;عن&nbsp;طريق&nbsp;الفم.</p><p dir="RTL">حجم&nbsp;العبوة: 30&nbsp;قرص</p><p dir="RTL">قد&nbsp;لا&nbsp;تكون&nbsp;جميع&nbsp;العبوات&nbsp;مسبوقة&nbsp;في&nbsp;بلدك)</p><p dir="RTL">&nbsp;</p><p dir="RTL">للإبلاغ&nbsp;عن&nbsp;أي&nbsp;أعراض&nbsp;جانبية:</p><p dir="RTL">المملكة&nbsp;العربية&nbsp;السعودية:</p><p dir="RTL">المركز&nbsp;الوطني&nbsp;للتيقظ&nbsp;الدوائي:</p><p dir="RTL">مركز&nbsp;الاتصال&nbsp;الموحد: 19999</p><p dir="RTL">البريد&nbsp;الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">الموقع&nbsp;الالكتروني: https://ade.sfda.gov.sa</p><p dir="RTL">والإمارات&nbsp;العربية&nbsp;المتحدة:</p><p dir="RTL">قسم&nbsp;اليقظة&nbsp;الدوائية&nbsp;والأجهزة&nbsp;الطبية</p><p dir="RTL">ص.ب: 1853،&nbsp;هاتف: 80011111</p><p dir="RTL">البريد&nbsp;الإلكتروني: pv@mohap.gov.ae</p><p dir="RTL">قسم&nbsp;الأدوية،&nbsp;وزارة&nbsp;الصحة&nbsp;و&nbsp;وقاية&nbsp;المجتمع</p><p dir="RTL">دبي-&nbsp;الإمارات&nbsp;العربية&nbsp;المتحدة</p><p dir="RTL">.&nbsp;دول&nbsp;الخليج&nbsp;العربي&nbsp;الأخرى:</p><p dir="RTL">الرجاء&nbsp;الاتصال&nbsp;بالجهات&nbsp;الوطنية&nbsp;في&nbsp;كل&nbsp;دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>مالك حق التسويق:</strong></p><p dir="RTL">مدينة الدواء للصناعات الدوائية - المملكة العربية السعودية.<br />الهاتف:&nbsp;00966920003288</p><p dir="RTL">فاكس:00966126358138 &nbsp;&nbsp;</p><p dir="RTL">ص.ب: 42512 - جدة 21551</p><p dir="RTL">البريد الكتروني:MD.admin@Axantia.com</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تصنيع</strong><strong>:</strong></p><p dir="RTL">الشركة الدولية للدواء- عمان - الأردن</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            10/2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Biscor® (Bisoprolol Fumarate 5 mg & 10 mg) F/C tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Biscor® 5 mg and 10 mg F/C Tablets.
For a full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets.
Biscor® 5 mg F/C tablets: are light orange oval, biconvex bisected, engraved with PhI on one face and VV1 on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.
Biscor® 10 mg F/C tablets: are light orange oval, biconvex bisected, engraved with PhI on one face and VV2on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of Hypertension</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of stable chronic angina</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ACE inhibitors, and diuretics, and optionally cardiac glycosides (for additional information see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Standard treatment of CHF consists of an ACE inhibitor (or an angiotensin receptor blocker in case of intolerance to ACE inhibitors, a beta-blocking agent, diuretics, and when appropriate cardiac glycosides, Patients should be stable (without acute failure) when bisoprolol treatment is initiated.</p><p>&nbsp;</p><p>It is recommended that the treating physician should be experienced in the management of chronic heart failure.</p><p>&nbsp;</p><p>Transient worsening of heart failure hypotension or bradycardia may occur during the titration period and thereafter.</p><p>&nbsp;</p><p><u>Titration Phase</u></p><p>&nbsp;</p><p>The treatment of stable chronic heart failure with bisoprolol requires a titration phase. The treatment with bisoprolol is to be started with a gradual uptitration according to the following steps:</p><p>&nbsp;</p><p>-&nbsp; 2.5 mg once daily for a further week, if well tolerated increase to</p><p>-&nbsp; 5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p>-&nbsp; 7.5 mg once daily for the 4 following weeks, if well tolerated increase to</p><p>-&nbsp; 10 mg once daily for the maintenance therapy</p><p>The maximum recommended dose is 10 mg once daily.</p><p>&nbsp;</p><p>Close monitoring of vital signs (heart rate, blood pressure) and symptoms of worsening heart failure is recommended during the titration phase. Symptoms may already occur within the first day after initiating therapy.</p><p>&nbsp;</p><p><u>Treatment Modification</u></p><p>&nbsp;</p><p>If the maximum recommended dose is not well tolerated, gradual dose reduction may be considered.</p><p>In case of transient worsening of heart failure, hypotension, or bradycardia reconsideration of the dosage of the concomitant medication is recommended. It may also be necessary to temporarily lower the dose of bisoprolol or to consider discontinuation. The reintroduction and/or uptitration of bisoprolol should always be considered when the patient becomes stable again. If discontinuation is considered, gradual dose decrease is recommended, since abrupt withdrawal may lead to acute deterioration of the patient&#39;s condition.</p><p>&nbsp;</p><p>Treatment of stable chronic heart failure with bisoprolol is generally a long-term treatment.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Bisoprolol Fumarate tablets should be taken in the morning and can be taken with food.</p><p>They should be swallowed with liquid and should not be chewed.</p><p><u>Special populations</u></p><p><em>Renal or liver impairment</em></p><p>&nbsp;</p><p>There is no information regarding pharmacokinetics of bisoprolol in patients with chronic heart failure and with impaired hepatic or renal function. Uptitration of the dose in these populations should therefore be made with additional caution.</p><p><em>Elderly</em></p><p>No dosage adjustment is required.</p><p><em>Paediatric Population</em></p><p>There is no experience with bisoprolol in children, therefore its use cannot be recommended for children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Bisoprolol is contraindicated in patients with:

-	Acute heart failure or during episodes of heart failure decompensation requiring i.v. inotropic therapy

-	Cardiogenic shock
-	Second or third degree AV block
-	Sick sinus syndrome
-	Sinoatrial block
-	Symptomatic bradycardia
-	Symptomatic hypotension
-	Severe bronchial asthma or severe chronic obstructive pulmonary disease

-	Severe forms of peripheral arterial occlusive disease or severe forms of Raynaud's syndrome

-	Untreated phaeochromocytoma (see section 4.4)
-	Metabolic acidosis
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Warnings</strong></p><p>&nbsp;</p><p>The treatment of stable chronic heart failure with bisoprolol has to be initiated with a special titration phase (see section 4.2).</p><p>Especially in patients with ischaemic heart disease the cessation of therapy with bisoprolol must not be done abruptly unless clearly indicated, because this may lead to transitional worsening of heart condition (see section 4.2).</p><p>&nbsp;</p><p><strong>Precautions</strong></p><p>&nbsp;</p><p>The initiation or cessation of treatment of stable chronic heart failure with bisoprolol necessitates regular monitoring. For the dosage and method of administration see section 4.2.</p><p>&nbsp;</p><p>There is no therapeutic experience of bisoprolol treatment in heart failure in patients with the following diseases and conditions:</p><p>&bull;&nbsp; Insulin-dependent diabetes mellitus (type I)</p><p>&bull;&nbsp; Severely impaired renal function</p><p>&bull;&nbsp; Severely impaired liver function</p><p>&bull;&nbsp; Restrictive cardiomyopathy</p><p>&bull;&nbsp; Congenital heart disease</p><p>&bull;&nbsp; Haemodynamically significant organic valvular disease</p><p>&bull;&nbsp; Myocardial infarction within 3 months</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp; Diabetes mellitus with large fluctuations in blood glucose values; symptoms of hypoglycaemia (e.g. tachycardia, palpitations or sweating) can be masked,</p><p>-&nbsp; Strict fasting,</p><p>-&nbsp; Ongoing desensitisation therapy. As with other beta-blockers, bisoprolol may increase both the sensitivity towards allergens and the severity of anaphylactic reactions. Epinephrine treatment may not always yield the expected therapeutic effect,</p><p>-&nbsp; First degree AV block,</p><p>-&nbsp; Prinzmetal&#39;s angina,</p><p>-&nbsp; Peripheral arterial occlusive disease. Aggravation of symptoms may occur especially when starting therapy.</p><p>&nbsp;</p><p>Patients with psoriasis or with a history of psoriasis should only be given beta-blockers (e.g. bisoprolol) after a careful balancing of benefits against risks.</p><p>&nbsp;</p><p>The symptoms of thyrotoxicosis may be masked under treatment with bisoprolol.</p><p>&nbsp;</p><p>In patients with phaeochromocytoma bisoprolol must not be administered until after alpha-receptor blockade.</p><p>&nbsp;</p><p>In patients undergoing general anaesthesia beta-blockade reduces the incidence of arrhythmias and myocardial ischemia during induction and intubation, and the post-operative period. It is currently recommended that maintenance of beta-blockade be continued peri-operatively. The anaesthesist must be aware of beta-blockade because of the potential for interactions with other drugs, resulting in bradyarrhythmias, attenuation of the reflex tachycardia, and decreased reflex ability to compensate for blood loss. If it is thought necessary to withdraw beta-blocker therapy before surgery, this should be done gradually and completed about 48 hours before anaesthesia.</p><p>&nbsp;</p><p>In bronchial asthma or other chronic obstructive pulmonary diseases, which may cause symptoms, concomitant bronchodilating therapy is recommended. Occasionally an increase of the airway resistance may occur in patients with asthma; therefore the dose of beta2-stimulants may have to be increased.</p><p>&nbsp;</p><p>Lactose: this medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&bull;&nbsp; <strong>Combinations not recommended</strong></p><p>&nbsp;</p><p>Class-I antiarrhythmic drugs (e.g. quinidine, disopyramide; lidocaine, phenytoin; flecainide, propafenone):</p><p>&nbsp;</p><p>&nbsp;</p><p>Effect on atrio-ventricular conduction time may be potentiated and negative inotropic effect increased.</p><p>&nbsp;</p><p>Calcium antagonists of the verapamil type and to a lesser extent of the diltiazem type:: Negative effect on contractility and atrio-ventricular conduction. Intravenous administration of verapamil in patients on beta-blocker treatment may lead to profound hypoension and atrio-ventricular block.</p><p>&nbsp;</p><p>Centrally-acting antihypertensive drugs (e.g. clonidine methyldopa, moxonidine, rilmenidine):</p><p>&nbsp;</p><p>Concomitant use of centrally-acting antihypertensive drugs may further decrease the central sympathetic tonus and may thus lead to reduction of heart rate and cardiac output and to vasodilatation. Abrupt withdrawal, particularly if prior to beta-blocker discontinuation, may increase the risk of &quot;rebound hypertension&quot;.</p><p>&nbsp;</p><p>&bull;&nbsp; <strong>Combinations to be used with caution</strong></p><p>&nbsp;</p><p>Calcium&nbsp; antagonists&nbsp;&nbsp; of&nbsp; the&nbsp;&nbsp; dihydropyridine&nbsp;&nbsp; type&nbsp;&nbsp; (e.g.&nbsp;&nbsp; felodipine&nbsp;&nbsp; and&nbsp;&nbsp; amlodipine):</p><p>&nbsp;</p><p>Concomitant use may increase the risk of hypotension, and an increase in the risk of</p><p>further deterioration of the ventricular pump function in patients with heart failure cannot</p><p>&nbsp;</p><p>be excluded.</p><p>Class-III antiarrhythmic drugs (e.g. amiodarone):</p><p>Effect on atrio-ventricular conduction time may be potentiated.</p><p>&nbsp;</p><p>Parasympathomimetic drugs:</p><p>&nbsp;</p><p>Concomitant use may increase atrio-ventricular conduction time and the risk of bradycardia.</p><p>&nbsp;</p><p>Topical beta-blockers (e.g. eye-drops for glaucoma treatment) may add to the systemic effects of bisoprolol.</p><p>&nbsp;</p><p>Insulin and oral antidiabetic drugs:</p><p>Increase of blood sugar lowering effect. Blockade of betaadrenoreceptors may mask</p><p>symptoms of hypoglycaemia.</p><p>Anaesthetic agents:</p><p>&nbsp;</p><p>Attenuation of the reflex tachycardia and increase of the risk of hypotension (for further information on general anaesthesia see section 4.4). Digitalis glycosides:</p><p>&nbsp;</p><p>Increase of atrio-ventricular conduction time, reduction in heart rate.</p><p>Non-steroidal anti-inflammatory drugs (NSAIDs):</p><p>NSAIDs may reduce the hypotensive effect of bisoprolol.</p><p>&nbsp;</p><p>Beta-sympathomimetics (eg. isoprenaline, dobutamine):</p><p>Combination with bisoprolol may reduce the effect of both agents.</p><p>Sympathomimetics&nbsp;&nbsp;&nbsp; that&nbsp;&nbsp;&nbsp;&nbsp; activate&nbsp;&nbsp;&nbsp;&nbsp; both&nbsp;&nbsp;&nbsp;&nbsp; beta-&nbsp;&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp;&nbsp;&nbsp; alpha-adrenoceptors&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (e.g.</p><p>norepinephrine, epinephrine):</p><p>&nbsp;</p><p>Combination with bisoprolol may unmask the alpha-adrenoceptor-mediated vasoconstrictor effects of these agents leading to blood pressure increase and exacerbated intermittent claudication. Such interactions are considered to be more likely with nonselective beta-blockers.</p><p>&nbsp;</p><p>Concomitant use with antihypertensive agents as well as with other drugs with blood pressure lowering potential (e.g. tricyclic antidepressants, barbiturates, phenothiazines) may increase the risk of hypotension.</p><p>&nbsp;</p><p>&bull;&nbsp; <strong>Combinations to be considered </strong>Mefloquine: increased risk of bradycardia.</p><p>&nbsp;</p><p>Monoamine oxidase inhibitors (except MAO-B inhibitors): Enhanced hypotensive effect of the beta-blockers but also risk of hypertensive crisis.</p><p>&nbsp;</p><p>Rifampicin: Slight reduction of the half-life of bisoprolol possible due to the induction of the hepatic drugmetabolising enzymes. Normally no dosage adjustment is necessary.</p><p>&nbsp;</p><p>Ergotamine derivatives: Exacerbation of peripheral circulatory disturbances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p><strong>(Pregnancy category C)</strong></p><p>&nbsp;</p><p>Bisoprolol has pharmacological effects that may cause harmful effects on pregnancy and/or the foetus/newborn. In general, beta-adrenoceptor blockers reduce placental perfusion, which has been associated with growth retardation, intrauterine death, abortion or early labour. Adverse effects (e.g. hypoglycaemia and bradycardia) may occur in the foetus and newborn infant. If treatment with beta-adrenoceptor blockers is necessary, beta1-selective adrenoceptor blockers are preferable.</p><p>&nbsp;</p><p>Bisoprolol is not recommended during pregnancy unless clearly necessary. If treatment is considered necessary, monitoring of the uteroplacental blood flow and the foetal growth is recommended. In case of harmful effects on pregnancy or the foetus consideration of alternative treatment is recommended. The newborn infant must be closely monitored. Symptoms of hypoglycaemia and bradycardia are generally to be expected within the first 3 days.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>&nbsp;</p><p>There is no data on the excretion of bisoprolol in human breast milk or the safety of bisoprolol exposure in infants. Therefore, breastfeeding is not recommended during administration of bisoprolol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In a study with coronary heart disease patients, bisoprolol did not impair driving performance.</p><p>&nbsp;</p><p>However, depending on the individual patients response to treatment an effect on the ability to drive a vehicle or to use machines may be impaired. This needs to be considered particularly at start of treatment, upon change of medication, or in conjunction with alcohol.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Very common (&ge;1/10),</p><p>Common (&ge;1/100 to &lt;1/10),</p><p>Uncommon (&ge;1/1,000to &lt;1/100),</p><p>&nbsp;</p><p>Rare (&ge;1/10,000 to &lt;1/1,000),</p><p>Very rare (&lt;1/10,000)</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="2" style="vertical-align:bottom"><p>Psychiatric disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Uncommon:</p></td><td style="vertical-align:bottom"><p>depression, sleep disorders</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Rare:</p></td><td style="vertical-align:bottom"><p>nightmares, hallucinations</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Nervous system disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Common:</p></td><td style="vertical-align:bottom"><p>dizziness, headache</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Rare:</p></td><td style="vertical-align:bottom"><p>syncope</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>Eye disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p>Rare:</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>reduced tear flow (to be considered if the patient uses contact</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>lenses)</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="7" style="vertical-align:bottom"><p>Very rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>conjunctivitis</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>hearing disorders</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Cardiac disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:bottom"><p>Very common:</p></td><td colspan="5" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>bradycardia</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Common:</p></td><td colspan="5" style="vertical-align:bottom"><p>worsening of pre-existing heart failure</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Uncommon:</p></td><td colspan="5" style="vertical-align:bottom"><p>AV-conduction disturbances</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Vascular disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="4" style="vertical-align:bottom"><p>Common:</p></td><td colspan="3" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>feeling&nbsp; of&nbsp; coldness&nbsp; or&nbsp; numbness&nbsp; in&nbsp; the&nbsp; extremities,</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>hypotension</p></td></tr><tr><td colspan="12" style="vertical-align:bottom"><p>Respiratory, thoracic and mediastinal disorders</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Uncommon:</p></td><td colspan="5" style="vertical-align:bottom"><p>bronchospasm in patients with bronchial asthma or a history</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>of obstructive airway disease</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>allergic rhinitis</p></td></tr><tr><td colspan="6" style="vertical-align:bottom"><p>Gastrointestinal disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Common:</p></td><td colspan="5" style="vertical-align:bottom"><p>gastrointestinal&nbsp;&nbsp; complaints&nbsp;&nbsp; such&nbsp;&nbsp; as&nbsp;&nbsp; nausea,&nbsp;&nbsp; vomiting,</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>diarrhoea, constipation</p></td></tr><tr><td colspan="5" style="vertical-align:bottom"><p>Hepatobiliary disorders</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>hepatitis</p></td></tr><tr><td colspan="8" style="vertical-align:bottom"><p>Skin and subcutaneous tissue disorders</p></td><td colspan="4" style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>hypersensitivity reactions such as itching, flush, rash</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Very rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>alopecia. Beta-blockers may provoke or worsen psoriasis or</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>induce psoriasis-like rash.</p></td></tr><tr><td colspan="11" style="vertical-align:bottom"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Uncommon:</p></td><td colspan="5" style="vertical-align:bottom"><p>muscle weakness, muscle cramps</p></td></tr><tr><td colspan="12" style="vertical-align:bottom"><p>Reproductive system and breast disorders</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="4" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="3" style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Rare:</p></td><td colspan="5" style="vertical-align:bottom"><p>potency disorders</p></td></tr><tr><td colspan="3" style="vertical-align:bottom"><p>General disorders</p></td><td colspan="4" style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Common:</p></td><td colspan="5" style="vertical-align:bottom"><p>asthenia, fatigue</p></td></tr><tr><td colspan="7" style="vertical-align:bottom"><p>Investigations</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p>Rare:</p></td><td colspan="6" style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>increased&nbsp; triglycerides,&nbsp; increased&nbsp; liver&nbsp; enzymes&nbsp; (ALAT,</p></td></tr><tr><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td style="vertical-align:bottom"><p>&nbsp;</p></td><td colspan="5" style="vertical-align:bottom"><p>ASAT)</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p><strong>&bull;Saudi Arabia:</strong></p><p>The National Pharmacovigilance Center (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p><strong>&bull;United Arab of Emirates:</strong></p><p>Pharmacovigilance and Medical Device Section</p><p>P.O. Box: 1853, Tel: 80011111</p><p>Email: pv@mohap.gov.ae</p><p>Drug Department, Ministry of Health &amp; Prevention</p><p>Dubai-UAE.</p><p><strong>&bull;Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Symptoms</em></strong></p><p>&nbsp;</p><p>The most common signs expected with overdose of a beta-blocker are bradycardia, hypotension, bronchospasm, acute cardiac insufficiency and hypoglycaemia. There is limited experience with overdose of bisoprolol, only a few cases of overdose with bisoprolol have been reported. Bradycardia and/or hypotension were noted. All patients recovered. There is a wide inter-individual variation in sensitivity to one single high dose of bisoprolol and patients with heart failure are probably very sensitive.</p><p>&nbsp;</p><p><strong><em>Management</em></strong></p><p>&nbsp;</p><p>In general, if overdose occurs, discontinuation of bisoprolol treatment and supportive and symptomatic treatment is recommended.</p><p>&nbsp;</p><p>Based on the expected pharmacologic actions and recommendations for other beta-blockers, the following general measures may be considered when clinically warranted. Bradycardia: Administer intravenous atropine. If the response is inadequate, isoprenaline or another agent with positive chronotropic properties may be given cautiously. Under some circumstances, transvenous pacemaker insertion may be necessary.</p><p>&nbsp;</p><p>Hypotension: Intravenous fluids and vasopressors should be administered. Intravenous glucagons may be useful.</p><p>&nbsp;</p><p>AV block (second or third degree): Patients should be carefully monitored and treated with isoprenaline infusion or temporary pacing.</p><p>&nbsp;</p><p>Acute worsening of heart failure: Administer i.v. diuretics, inotropic agents, vasodilating agents.</p><p>&nbsp;</p><p>Bronchospasm: Administer bronchodilator therapy such as isoprenaline, beta2-sympathomimetic drugs and/or aminophylline. Hypoglycaemia:Administer i.v.-glucose.</p><p>&nbsp;</p><p>Limited data suggest that bisoprolol is hardly dialysable.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Beta-blocking agents, selective</p><p>&nbsp;</p><p>ATC code: C07_AB07</p><p>&nbsp;</p><p>Bisoprolol is a highly beta1-selective-adrenoceptor blocking agent, lacking intrinsic stimulating and relevant membrane stabilising activity. It only shows low affinity to the beta2-receptor of the smooth muscles of bronchi and vessels as well as to the beta2-receptors concerned with metabolic regulation. Therefore, bisoprolol is generally not to be expected to influence the airway resistance and beta2-mediated metabolic effects. Its beta1-selectivity extends beyond the therapeutic dose range.</p><p>&nbsp;</p><p>&nbsp;</p><p>In total 2647 patients were included in the CIBIS II trial. 83% (n = 2202) were in NYHA class III and 17% (n = 445) were in NYHA class IV. They had stable symptomatic systolic heart failure (ejection fraction &lt;35%, based on echocardiography). Total mortality was reduced from 17.3% to 11.8% (relative reduction 34%). A decrease in sudden death (3.6% vs 6.3%, relative reduction 44%) and a reduced number of heart failure episodes requiring hospital admission (12% vs 17.6%, relative reduction 36%) was observed. Finally, a significant improvement of the functional status according to NYHA classification has been shown. During the initiation and titration of bisoprolol hospital admission due to bradycardia (0.53%), hypotension (0.23%), and acute decompensation (4.97%) were observed, but they were not more frequent than in the placebo-group (0%, 0.3% and 6.74%). The numbers of fatal and disabling strokes during the total study period were 20 in the bisoprolol group and 15 in the placebo group.</p><p>&nbsp;</p><p>The CIBIS III trial investigated 1010 patients aged &ge;65 years with mild to moderate chronic heart failure (CHF; NYHA class II or III) and left ventricular ejection fraction &le;35%, who had not been treated previously with ACE inhibitors, beta-blocking agents, or angiotensin receptor blockers. Patients were treated with a combination of bisoprolol and enalapril for 6 to 24 months after an initial 6 months treatment with either bisoprolol or enalapril.</p><p>&nbsp;</p><p>There was a trend toward higher frequency of chronic heart failure worsening when bisoprolol was used as the initial 6 months treatment. Non inferiority of bisoprolol-first versus enalapril-first treatment was not proven in the per-protocol analysis, although the two strategies for initiation of CHF treatment showed a similar rate of the primary combined endpoint death and hospitalization at study end (32.4% in the bisoprolol-first group vs. 33.1% in the enalapril-first group, per-protocol population). The study shows that bisoprolol can also be used in elderly chronic heart failure patients with mild to moderate disease.</p><p>&nbsp;</p><p>Bisoprolol is also used for the treatment of hypertension and angina.</p><p>&nbsp;</p><p>In acute administration in patients with coronary heart disease without chronic heart failure bisoprolol reduces the heart rate and stroke volume and thus the cardiac output and oxygen consumption. In chronic administration the initially elevated peripheral resistance decreases.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bisoprolol is absorbed and has a biological availability of about 90% after oral administration. The plasma protein binding of bisoprolol is about 30%. The distribution volume is 3.5 l/kg. Total clearance is approximately 15 l/h.</p><p>&nbsp;</p><p>The half-life in plasma of 10-12 hours gives a 24 hour effect after dosing once daily. Bisoprolol is excreted from the body by two routes, 50 % is metabolised by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50 % is excreted by the kidneys in an unmetabolised form. Since elimination takes place in the kidneys and the liver to the same extent a dosage adjustment is not required for patients with impaired liver function or renal insufficiency. The pharmacokinetics in patients with stable chronic heart failure and with impaired liver or renal function has not been studied. The kinetics of bisoprolol is linear and independent of age.</p><p>&nbsp;</p><p>In patients with chronic heart failure (NYHA stage III) the plasma levels of bisoprolol are higher and the half-life is prolonged compared to healthy volunteers. Maximum plasma concentration at steady state is 64&plusmn;21 ng/ml at a daily dose of 10 mg and the half-life is 17&plusmn;5 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity or carcinogenicity. Like other beta-blocking agents, bisoprolol caused maternal (decreased food intake and decreased body weight) and embryo/fetal toxicity (increased incidence of resorptions, reduced birth weight of the offspring, retarded physical development) at high doses but was not teratogenic.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>calcium hydrogen phosphate anhydrous, maize starch, povidone K, sodium starch glycolate, microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, Opadry OY-L white, FD&amp;C yellow #6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Biscor</strong><strong><sup>&reg;</sup></strong><strong> 5 mg F/C tablets: </strong>are light orange oval, biconvex bisected, engraved with PhI<strong> </strong>on one face and VV1 on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.</p><p>&nbsp;</p><p><strong>Pack size: </strong>30 and 500 Tablets.</p><p>&nbsp;</p><p><strong>Biscor</strong><strong><sup>&reg;</sup></strong><strong> 10 mg F/C tablets: </strong>are light orange oval, biconvex bisected, engraved with PhI<strong> </strong>on one face and VV2 on the other, packed in PVC/TE/PVDC-Alu blisters, intended for oral use.</p><p>&nbsp;</p><p><strong>Pack size: </strong>30 Tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Marketing Authorization Holder: 
Med City Pharma-KSA. 
Tel: 00966920003288 
Fax: 00966126358138 
Mobile: 00966555786968 
P.O .Box: 42512 - Jeddah 21551 
E-mail: MD.admin@Axantia.com 

Manufactured by: 
Pharma International Company. Amman – Jordan.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>